Neptune Technologies and Bioressources Inc.   Report issue

For profit Phase 4
Founded: Laval Canada (1925)
Status: No NME R&D (1925)

Organization Overview

First Clinical Trial
2009
NCT00867828
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

NeuroBioPharm Inc.